Chronic corticosterone administration dose-dependently modulates Aβ((1-42))- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis

I. Ábrahám, T. Harkany, K. M. Horvath, A. H. Veenema, B. Penke, C. Nyakas, P. G M Luiten

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The impact of glucocorticoids on β-amyloid((1-42)) (Aβ((1-42))) and NMDA-induced neurodegeneration was investigated in vivo. Aβ((1-42)) or NMDA was injected into the cholinergic magnocellular nucleus basalis in adrenalectomized (ADX) rats, ADX rats supplemented with 25%, 100%, 2 x 100% corticosterone pellets, or sham-ADX controls. Aβ((1-42))- or NMDA-induced damage of cholinergic nucleus basalis neurones was assessed by quantitative acetylcholinesterase histochemistry. Plasma concentrations of corticosterone and cholinergic fibre loss after Aβ((1-42)) or NMDA injection showed a clear U-shaped dose-response relationship. ADX and subsequent loss of serum corticosterone potentiated both the Aβ((1-42)) and NMDA-induced neurodegeneration. ADX + 25% corticosterone resulted in a 10-90 nM plasma corticosterone concentration, which significantly attenuated the Aβ((1-42)) and NMDA neurotoxicity. ADX + 100% corticosterone (corticosterone concentrations of 110-270 nM) potently decreased both Aβ((1-42))- and NMDA-induced neurotoxic brain damage. In contrast, high corticosterone concentrations of 310-650 nM potentiated Aβ((1-42))- and NMDA-triggered neurodegeneration. In conclusion, chronic low or high corticosterone concentrations increase the vulnerability of cholinergic cells to neurotoxic insult, while slightly elevated corticosterone levels protect against neurotoxic injury. Enhanced neurotoxicity of NMDA in the presence of high concentrations of specific glucocorticoid receptor agonists suggests that the corticosterone effects are mediated by glucocorticoid receptors.

Original languageEnglish
Pages (from-to)486-494
Number of pages9
JournalJournal of Neuroendocrinology
Volume12
Issue number6
DOIs
Publication statusPublished - 2000

Fingerprint

N-Methylaspartate
Corticosterone
Cholinergic Agents
Glucocorticoid Receptors
Cholinergic Fibers
Acetylcholinesterase
Amyloid
Glucocorticoids
Neurons
Injections

Keywords

  • β-amyloid
  • Corticosterone
  • Excitotoxicity
  • Neurodegeneration
  • Neuroprotection

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Chronic corticosterone administration dose-dependently modulates Aβ((1-42))- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. / Ábrahám, I.; Harkany, T.; Horvath, K. M.; Veenema, A. H.; Penke, B.; Nyakas, C.; Luiten, P. G M.

In: Journal of Neuroendocrinology, Vol. 12, No. 6, 2000, p. 486-494.

Research output: Contribution to journalArticle

@article{d03c7ad8169544fc9006e1f7e7968121,
title = "Chronic corticosterone administration dose-dependently modulates Aβ((1-42))- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis",
abstract = "The impact of glucocorticoids on β-amyloid((1-42)) (Aβ((1-42))) and NMDA-induced neurodegeneration was investigated in vivo. Aβ((1-42)) or NMDA was injected into the cholinergic magnocellular nucleus basalis in adrenalectomized (ADX) rats, ADX rats supplemented with 25{\%}, 100{\%}, 2 x 100{\%} corticosterone pellets, or sham-ADX controls. Aβ((1-42))- or NMDA-induced damage of cholinergic nucleus basalis neurones was assessed by quantitative acetylcholinesterase histochemistry. Plasma concentrations of corticosterone and cholinergic fibre loss after Aβ((1-42)) or NMDA injection showed a clear U-shaped dose-response relationship. ADX and subsequent loss of serum corticosterone potentiated both the Aβ((1-42)) and NMDA-induced neurodegeneration. ADX + 25{\%} corticosterone resulted in a 10-90 nM plasma corticosterone concentration, which significantly attenuated the Aβ((1-42)) and NMDA neurotoxicity. ADX + 100{\%} corticosterone (corticosterone concentrations of 110-270 nM) potently decreased both Aβ((1-42))- and NMDA-induced neurotoxic brain damage. In contrast, high corticosterone concentrations of 310-650 nM potentiated Aβ((1-42))- and NMDA-triggered neurodegeneration. In conclusion, chronic low or high corticosterone concentrations increase the vulnerability of cholinergic cells to neurotoxic insult, while slightly elevated corticosterone levels protect against neurotoxic injury. Enhanced neurotoxicity of NMDA in the presence of high concentrations of specific glucocorticoid receptor agonists suggests that the corticosterone effects are mediated by glucocorticoid receptors.",
keywords = "β-amyloid, Corticosterone, Excitotoxicity, Neurodegeneration, Neuroprotection",
author = "I. {\'A}brah{\'a}m and T. Harkany and Horvath, {K. M.} and Veenema, {A. H.} and B. Penke and C. Nyakas and Luiten, {P. G M}",
year = "2000",
doi = "10.1046/j.1365-2826.2000.00475.x",
language = "English",
volume = "12",
pages = "486--494",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Chronic corticosterone administration dose-dependently modulates Aβ((1-42))- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis

AU - Ábrahám, I.

AU - Harkany, T.

AU - Horvath, K. M.

AU - Veenema, A. H.

AU - Penke, B.

AU - Nyakas, C.

AU - Luiten, P. G M

PY - 2000

Y1 - 2000

N2 - The impact of glucocorticoids on β-amyloid((1-42)) (Aβ((1-42))) and NMDA-induced neurodegeneration was investigated in vivo. Aβ((1-42)) or NMDA was injected into the cholinergic magnocellular nucleus basalis in adrenalectomized (ADX) rats, ADX rats supplemented with 25%, 100%, 2 x 100% corticosterone pellets, or sham-ADX controls. Aβ((1-42))- or NMDA-induced damage of cholinergic nucleus basalis neurones was assessed by quantitative acetylcholinesterase histochemistry. Plasma concentrations of corticosterone and cholinergic fibre loss after Aβ((1-42)) or NMDA injection showed a clear U-shaped dose-response relationship. ADX and subsequent loss of serum corticosterone potentiated both the Aβ((1-42)) and NMDA-induced neurodegeneration. ADX + 25% corticosterone resulted in a 10-90 nM plasma corticosterone concentration, which significantly attenuated the Aβ((1-42)) and NMDA neurotoxicity. ADX + 100% corticosterone (corticosterone concentrations of 110-270 nM) potently decreased both Aβ((1-42))- and NMDA-induced neurotoxic brain damage. In contrast, high corticosterone concentrations of 310-650 nM potentiated Aβ((1-42))- and NMDA-triggered neurodegeneration. In conclusion, chronic low or high corticosterone concentrations increase the vulnerability of cholinergic cells to neurotoxic insult, while slightly elevated corticosterone levels protect against neurotoxic injury. Enhanced neurotoxicity of NMDA in the presence of high concentrations of specific glucocorticoid receptor agonists suggests that the corticosterone effects are mediated by glucocorticoid receptors.

AB - The impact of glucocorticoids on β-amyloid((1-42)) (Aβ((1-42))) and NMDA-induced neurodegeneration was investigated in vivo. Aβ((1-42)) or NMDA was injected into the cholinergic magnocellular nucleus basalis in adrenalectomized (ADX) rats, ADX rats supplemented with 25%, 100%, 2 x 100% corticosterone pellets, or sham-ADX controls. Aβ((1-42))- or NMDA-induced damage of cholinergic nucleus basalis neurones was assessed by quantitative acetylcholinesterase histochemistry. Plasma concentrations of corticosterone and cholinergic fibre loss after Aβ((1-42)) or NMDA injection showed a clear U-shaped dose-response relationship. ADX and subsequent loss of serum corticosterone potentiated both the Aβ((1-42)) and NMDA-induced neurodegeneration. ADX + 25% corticosterone resulted in a 10-90 nM plasma corticosterone concentration, which significantly attenuated the Aβ((1-42)) and NMDA neurotoxicity. ADX + 100% corticosterone (corticosterone concentrations of 110-270 nM) potently decreased both Aβ((1-42))- and NMDA-induced neurotoxic brain damage. In contrast, high corticosterone concentrations of 310-650 nM potentiated Aβ((1-42))- and NMDA-triggered neurodegeneration. In conclusion, chronic low or high corticosterone concentrations increase the vulnerability of cholinergic cells to neurotoxic insult, while slightly elevated corticosterone levels protect against neurotoxic injury. Enhanced neurotoxicity of NMDA in the presence of high concentrations of specific glucocorticoid receptor agonists suggests that the corticosterone effects are mediated by glucocorticoid receptors.

KW - β-amyloid

KW - Corticosterone

KW - Excitotoxicity

KW - Neurodegeneration

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=0342369460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342369460&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2826.2000.00475.x

DO - 10.1046/j.1365-2826.2000.00475.x

M3 - Article

VL - 12

SP - 486

EP - 494

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 6

ER -